questionsmedicales.fr
Structures de l'embryon
Feuillets embryonnaires
Feuillets embryonnaires : Questions médicales fréquentes
Termes MeSH sélectionnés :
Early Detection of Cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Feuillets embryonnaires : Questions médicales les plus fréquentes",
"headline": "Feuillets embryonnaires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Feuillets embryonnaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-24",
"dateModified": "2025-04-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Feuillets embryonnaires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Structures de l'embryon",
"url": "https://questionsmedicales.fr/mesh/D004628",
"about": {
"@type": "MedicalCondition",
"name": "Structures de l'embryon",
"code": {
"@type": "MedicalCode",
"code": "D004628",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A16"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ectoderme",
"alternateName": "Ectoderm",
"url": "https://questionsmedicales.fr/mesh/D004475",
"about": {
"@type": "MedicalCondition",
"name": "Ectoderme",
"code": {
"@type": "MedicalCode",
"code": "D004475",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A16.504.273"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Endoderme",
"alternateName": "Endoderm",
"url": "https://questionsmedicales.fr/mesh/D004707",
"about": {
"@type": "MedicalCondition",
"name": "Endoderme",
"code": {
"@type": "MedicalCode",
"code": "D004707",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A16.504.407"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mésoderme",
"alternateName": "Mesoderm",
"url": "https://questionsmedicales.fr/mesh/D008648",
"about": {
"@type": "MedicalCondition",
"name": "Mésoderme",
"code": {
"@type": "MedicalCode",
"code": "D008648",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A16.504.660"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Péricytes",
"alternateName": "Pericytes",
"url": "https://questionsmedicales.fr/mesh/D020286",
"about": {
"@type": "MedicalCondition",
"name": "Péricytes",
"code": {
"@type": "MedicalCode",
"code": "D020286",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A16.504.660.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Somites",
"alternateName": "Somites",
"url": "https://questionsmedicales.fr/mesh/D019170",
"about": {
"@type": "MedicalCondition",
"name": "Somites",
"code": {
"@type": "MedicalCode",
"code": "D019170",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A16.504.660.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Feuillets embryonnaires",
"alternateName": "Germ Layers",
"code": {
"@type": "MedicalCode",
"code": "D005855",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Elizabeth R Gavis",
"url": "https://questionsmedicales.fr/author/Elizabeth%20R%20Gavis",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Biology, Princeton University, Princeton, New Jersey, United States of America."
}
},
{
"@type": "Person",
"name": "Bernard K van der Veer",
"url": "https://questionsmedicales.fr/author/Bernard%20K%20van%20der%20Veer",
"affiliation": {
"@type": "Organization",
"name": "Laboratory for Stem Cell and Developmental Epigenetics, Department of Development and Regeneration, Katholieke Universiteit Leuven, 3000 Leuven, Belgium."
}
},
{
"@type": "Person",
"name": "Kian Peng Koh",
"url": "https://questionsmedicales.fr/author/Kian%20Peng%20Koh",
"affiliation": {
"@type": "Organization",
"name": "Laboratory for Stem Cell and Developmental Epigenetics, Department of Development and Regeneration, Katholieke Universiteit Leuven, 3000 Leuven, Belgium."
}
},
{
"@type": "Person",
"name": "Ulrich Technau",
"url": "https://questionsmedicales.fr/author/Ulrich%20Technau",
"affiliation": {
"@type": "Organization",
"name": "Department for Molecular Evolution and Development, Centre of Organismal Systems Biology, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria ulrich.technau@univie.ac.at."
}
},
{
"@type": "Person",
"name": "Patrick P L Tam",
"url": "https://questionsmedicales.fr/author/Patrick%20P%20L%20Tam",
"affiliation": {
"@type": "Organization",
"name": "Embryology Research Unit, Children's Medical Research Institute, and School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A Rare Case of Renal Malakoplakia Incidentally Detected on 18F-FDG PET/CT in a Patient With Concomitant Breast Cancer and Lymphoma.",
"datePublished": "2024-06-03",
"url": "https://questionsmedicales.fr/article/38861402",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RLU.0000000000005310"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of breast fine-needle aspiration cytology and tissue sampling for high-throughput proteomic analysis and cancer biomarker detection.",
"datePublished": "2024-05-30",
"url": "https://questionsmedicales.fr/article/38815563",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000539478"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Impact of Prostate Volume on Prostate Cancer Detection: Comparing Magnetic Resonance Imaging with Transrectal Ultrasound in Biopsy-naïve Men.",
"datePublished": "2024-04-22",
"url": "https://questionsmedicales.fr/article/38694877",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.euros.2024.04.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human epididymal protein 4 and its combined detection show good diagnostic value in lung cancer: A retrospective study.",
"datePublished": "2024-04-15",
"url": "https://questionsmedicales.fr/article/38619974",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/03936155241244802"
}
},
{
"@type": "ScholarlyArticle",
"name": "Enhancing Colorectal Cancer Tumor Bud Detection Using Deep Learning from Routine H&E-Stained Slides.",
"datePublished": "2024-04-03",
"url": "https://questionsmedicales.fr/article/38752165",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1117/12.3006796"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Structures de l'embryon",
"item": "https://questionsmedicales.fr/mesh/D004628"
},
{
"@type": "ListItem",
"position": 3,
"name": "Feuillets embryonnaires",
"item": "https://questionsmedicales.fr/mesh/D005855"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Feuillets embryonnaires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Feuillets embryonnaires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Feuillets embryonnaires",
"description": "Comment identifier les feuillets embryonnaires ?\nQuels examens sont utilisés pour étudier les feuillets ?\nPeut-on détecter des anomalies des feuillets ?\nQuels signes indiquent des problèmes embryonnaires ?\nLes feuillets peuvent-ils être visualisés directement ?",
"url": "https://questionsmedicales.fr/mesh/D005855?mesh_terms=Early+Detection+of+Cancer&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Feuillets embryonnaires",
"description": "Quels symptômes sont liés aux anomalies des feuillets ?\nLes anomalies des feuillets affectent-elles le développement ?\nComment les anomalies se manifestent-elles ?\nLes symptômes varient-ils selon le feuillet affecté ?\nLes symptômes sont-ils toujours présents à la naissance ?",
"url": "https://questionsmedicales.fr/mesh/D005855?mesh_terms=Early+Detection+of+Cancer&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Feuillets embryonnaires",
"description": "Comment prévenir les anomalies des feuillets embryonnaires ?\nLe dépistage prénatal aide-t-il à prévenir les anomalies ?\nLes vaccinations sont-elles importantes pendant la grossesse ?\nLe stress maternel influence-t-il le développement embryonnaire ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D005855?mesh_terms=Early+Detection+of+Cancer&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Feuillets embryonnaires",
"description": "Quels traitements existent pour les anomalies des feuillets ?\nPeut-on prévenir les anomalies des feuillets ?\nLes traitements sont-ils efficaces ?\nY a-t-il des traitements expérimentaux ?\nLes traitements nécessitent-ils un suivi ?",
"url": "https://questionsmedicales.fr/mesh/D005855?mesh_terms=Early+Detection+of+Cancer&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Feuillets embryonnaires",
"description": "Quelles complications peuvent survenir avec des anomalies des feuillets ?\nLes complications sont-elles toujours visibles à la naissance ?\nLes anomalies des feuillets augmentent-elles le risque de maladies ?\nLes complications peuvent-elles être traitées ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D005855?mesh_terms=Early+Detection+of+Cancer&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Feuillets embryonnaires",
"description": "Quels sont les facteurs de risque pour les anomalies des feuillets ?\nL'exposition à des toxines influence-t-elle le développement ?\nLes maladies maternelles affectent-elles le fœtus ?\nLe mode de vie maternel joue-t-il un rôle ?\nLes traitements médicaux peuvent-ils influencer le développement ?",
"url": "https://questionsmedicales.fr/mesh/D005855?mesh_terms=Early+Detection+of+Cancer&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les feuillets embryonnaires ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'identification se fait par l'observation des couches cellulaires lors de l'embryogenèse."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour étudier les feuillets ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie et l'imagerie par résonance magnétique (IRM) sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des anomalies des feuillets ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies peuvent être détectées par des tests génétiques et des échographies."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent des problèmes embryonnaires ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des malformations ou des retards de développement peuvent indiquer des problèmes."
}
},
{
"@type": "Question",
"name": "Les feuillets peuvent-ils être visualisés directement ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils sont généralement étudiés par des méthodes indirectes comme l'imagerie."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux anomalies des feuillets ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des malformations physiques et des troubles fonctionnels."
}
},
{
"@type": "Question",
"name": "Les anomalies des feuillets affectent-elles le développement ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des retards de croissance et des dysfonctionnements organiques."
}
},
{
"@type": "Question",
"name": "Comment les anomalies se manifestent-elles ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent se manifester par des malformations visibles ou des troubles internes."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le feuillet affecté ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque feuillet (ectoderme, mésoderme, endoderme) a des implications spécifiques."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents à la naissance ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, certaines anomalies peuvent se développer plus tard dans l'enfance."
}
},
{
"@type": "Question",
"name": "Comment prévenir les anomalies des feuillets embryonnaires ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée, l'évitement de substances nocives et des soins prénatals sont cruciaux."
}
},
{
"@type": "Question",
"name": "Le dépistage prénatal aide-t-il à prévenir les anomalies ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage permet d'identifier les risques et d'agir en conséquence."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes pendant la grossesse ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations protègent le fœtus contre des infections pouvant causer des anomalies."
}
},
{
"@type": "Question",
"name": "Le stress maternel influence-t-il le développement embryonnaire ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un stress élevé peut affecter le développement et augmenter le risque d'anomalies."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux d'anomalies peuvent augmenter le risque pour le fœtus."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les anomalies des feuillets ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements varient de la chirurgie corrective à la thérapie génique selon l'anomalie."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies des feuillets ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies peuvent être prévenues par une bonne nutrition et des soins prénatals."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité dépend de la nature et de la gravité de l'anomalie détectée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des recherches sont en cours sur des thérapies innovantes pour certaines anomalies."
}
},
{
"@type": "Question",
"name": "Les traitements nécessitent-ils un suivi ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est essentiel pour évaluer l'évolution et ajuster les soins."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des anomalies des feuillets ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des malformations graves, des troubles fonctionnels et des décès néonatals."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles toujours visibles à la naissance ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certaines complications peuvent se manifester plus tard dans l'enfance."
}
},
{
"@type": "Question",
"name": "Les anomalies des feuillets augmentent-elles le risque de maladies ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent prédisposer à des maladies chroniques ou à des troubles du développement."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être traitées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées par des traitements médicaux ou chirurgicaux."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent avoir un impact significatif sur la qualité de vie de l'individu."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les anomalies des feuillets ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge maternel avancé, des antécédents familiaux et des infections."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines influence-t-elle le développement ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines environnementales peut augmenter le risque d'anomalies."
}
},
{
"@type": "Question",
"name": "Les maladies maternelles affectent-elles le fœtus ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies, comme le diabète, peuvent augmenter le risque d'anomalies congénitales."
}
},
{
"@type": "Question",
"name": "Le mode de vie maternel joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme, l'alcool et une mauvaise nutrition sont des facteurs de risque importants."
}
},
{
"@type": "Question",
"name": "Les traitements médicaux peuvent-ils influencer le développement ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent être tératogènes et affecter le développement embryonnaire."
}
}
]
}
]
}
Malakoplakia is a rare inflammatory disease that most frequently affects the urinary tract. We present the case of a patient who had been receiving treatment for breast cancer, who later on went on to...
Fine-needle aspiration cytology (FNAC) specimens are widely utilized for the diagnosis and molecular testing of various cancers. We performed a comparative proteomic analysis of three different sample...
High-throughput proteomic analysis was conducted on matched FNAC, CNB, and surgical resection tissue samples obtained from breast cancer patients. The protein identification, including currently estab...
Compared to tissue samples, FNAC testing revealed a comparable number of proteins (7,179 in FNAC; 7,196 in CNB; 7,190 in resection samples). Around 85% of proteins were mutually identified in all samp...
FNAC is suitable for high-throughput proteomic analysis, in addition to an emerging source that could be used to identify and quantify novel cancer biomarkers....
This study aimed to determine the difference in prostate volume (PV) derived from transrectal ultrasound (TRUS) and multiparametric magnetic resonance imaging (mpMRI), and to further investigate the r...
Patients who underwent an initial prostate biopsy within 3 mo after mpMRI between January 2016 and December 2021 were analyzed retrospectively. The sensitivity, specificity, positive predictive value ...
The median prostate-specific antigen level of 875 patients was 9.79 (interquartile range [IQR]: 7.09-13.50) ng/ml. The median mpMRI-PV and TRUS-PV were 41.92 (IQR: 29.29-60.73) and 41.04 (IQR: 29.24-5...
TRUS-PV and MRI-PV exhibited a strong linear correlation and reached sufficient agreement. The efficiency of TRUS-PSAD and mpMRI-PSAD for PCa detection was comparable. TRUS could be used for PV estima...
In this work, prostate volume (PV) derived from transrectal ultrasound (TRUS) exhibited a strong linear correlation with the PV derived from multiparametric magnetic resonance imaging (mpMRI). The eff...
This study aimed to assess the diagnostic value of human epididymal protein 4 (HE4), a potential novel biomarker for lung cancer, and its combined detection with five other conventional biomarkers in ...
In this retrospective study, 115 lung cancer patients, 50 patients with benign pulmonary disease, and 50 healthy controls were included. Serum HE4, progastrin-releasing peptide (ProGRP), squamous cell...
All six biomarkers showed significantly elevated levels in the lung cancer group compared to both benign pulmonary disease and control groups (...
HE4 and its combined detection held substantial clinical significance in the diagnosis of lung cancer and its histologic subtyping, especially for lung adenocarcinoma and lung squamous cell carcinoma....
Tumor budding refers to a cluster of one to four tumor cells located at the tumor-invasive front. While tumor budding is a prognostic factor for colorectal cancer, counting and grading tumor budding a...
To compare the diagnostic performance of 40 keV and 70 keV virtual monoenergetic images (VMIs) generated from dual-energy CT in the detection of pancreatic cancer....
This retrospective study included patients who underwent pancreatic protocol dual-energy CT from January 2019 to August 2022. Four radiologists (1-11 years of experience), who were blinded to the fina...
Overall, 137 patients (median age, 71 years; interquartile range, 63-78 years; 77 men) were included. Among them, 62 patients (45%) had pathologically proven pancreatic cancer. The 40 keV VMIs had hig...
The 40 keV VMIs showed better diagnostic performance in diagnosing pancreatic cancer than the 70 keV VMIs, along with higher reader confidence....
Surface-enhanced Raman scattering (SERS) technology have unique advantages of rapid, simple, and highly sensitive in the detection of serum, it can be used for the detection of liver cancer. However, ...
Serum samples were collected from 60 patients with liver cancer (27 patients with stage T1 and T2 liver cancer, 33 patients with stage T3 and T4 liver cancer) and 40 healthy volunteers. Herein, immuno...
The experimental results show that the serum LAPs SERS detection combined with multivariate statistical algorithms can be used for effectively distinguishing liver cancer patients from healthy volunte...
This study investigated the potential ability of the fluorescent probe Ly-CHO to detect formaldehyde (FA) in living cells and tumor-bearing mice. Ly-CHO exhibited great selectivity, excellent sensitiv...
A 62-year-old woman with follicular thyroid cancer who had received total thyroidectomy and multiple rounds of radioactive iodine therapy underwent both 18F-FDG and 18F-FAPI PET/CT. 18F-FAPI PET faile...
Prostate cancer is one of the most common malignancies affecting elderly men worldwide and the fifth leading cause of cancer death in men. Prostate cancer includes many histological variants with the ...